Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	14.12	13.16	11.53
Graham Fair Price	-10.81	11913.69	13357.57
PEG	-16.11	-0.39	-0.34
Price/Book	10.38	0.45	0.41
Price/Cash Flow	-56.40	17.74	-40.68
Prices/Earnings	34.88	7.06	5.23
Price/Sales	14.90	1.76	1.53
Price/FCF	-56.40	17.74	-40.68
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.06	0.19	0.18
Operating Margin	-1.94	0.07	0.07
ROA	-20.17	0.01	0.02
ROE	0.02	0.02	-18.16
ROIC	0.01	0.01	-18.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.13	-0.18	-29.74
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.30	-0.07	78.30
EPS QOQ	-0.15	-0.18	-16.16
FCF QOQ	-1.75	3.51	101.06
Revenue QOQ	0.01	-0.05	252.13
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	39.06	42.10	7.78
Days Sales Outstanding (DSO)	56.28	56.63	0.62
Inventory Turnover	2.30	2.14	-7.22
Debt/Capitalization	0.08	0.09	13.36
Quick Ratio	2.09	1.92	-7.95
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	20064.85	19781.97	-1.41
Cash	4178.78	4771.61	14.19
Capex	-948.52	-157.90	83.35
Free Cash Flow	-203.29	507.41	149.60
Revenue	5406.14	5120.44	-5.28
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.64	2.41	-8.60
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.93	-1.16	-25.18
Naive Interpretation	Member

06 - Financial Health · Bad

Rating